Utah Medical Products (UTMD) Reports Q4 EPS of $0.85

Go back to Utah Medical Products (UTMD) Reports Q4 EPS of $0.85

Utah Medical Products Reports Audited Financial Performance for Fourth Quarter and Year 2015

February 2, 2016 9:03 AM EST

SALT LAKE CITY, UT -- (Marketwired) -- 02/02/16 -- Utah Medical Products, Inc. (NASDAQ: UTMD) concluded a financial year in 2015 dominated by changes in foreign currency exchange (FX) rates. Despite a weak fourth calendar quarter (4Q) due to international distributor order patterns, revenues for the year were up 1% on a constant currency basis. Earnings per share (EPS) were also up 1% excluding a "windfall" increase in 4Q 2015 net profits that resulted from the UK again lowering corporate income tax rates.

The results according to U.S. Generally Accepted Accounting Principles (US GAAP) are clouded... More